Virtual Reality Rehabilitation for Patients With Anterior Cruciate Ligament Reconstruction

April 16, 2024 updated by: Prof. Maria V. Sanchez-Vives, Institut d'Investigacions Biomèdiques August Pi i Sunyer

Early Domestic Rehabilitation Using Virtual Reality for Patients With Anterior Cruciate Ligament Reconstruction: a Randomized Controlled Trial

The purpose of this study is to ascertain whether 4 weeks of daily virtual-reality-based rehabilitation at home improves disability in the early stages of recovery from anterior cruciate ligament reconstruction surgery compared with standard care.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

After being informed about the study and potential risks and benefits, patients giving written informed consent will be randomized to one of two groups in a 1:1 ratio. The treatment group will perform daily a 20-minute rehabilitation session in virtual reality, in which they will observe their virtual body performing a series of exercises they would otherwise be unable to perform in real life. Both groups will also undergo the standard rehabilitation protocol. The investigators will assess for differences between groups in self-reported disability, knee range of motion, and quadriceps strength at baseline, 4 weeks, 12 weeks and 9 months.

Study Type

Interventional

Enrollment (Actual)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Maria V. Sanchez-Vives, PhD
  • Phone Number: 4379/4302 93 227 5400
  • Email: msanche3@clinic.cat

Study Contact Backup

Study Locations

      • Barcelona, Spain, 08036
        • IDIBAPS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Aged 18-40 (either sex)
  • Post-operative anterior cruciate ligament reconstruction (autograft), either bone-patellar tendon-bone graft or semitendinosus (hamstring) graft

Exclusion Criteria:

  • Patients with significant cognitive deficit (MEC<24).
  • Patients with epilepsy or severe vision problems
  • Pregnant patients
  • Previous surgery on the reconstructed knee, excluding arthroscopy
  • Previous anterior cruciate ligament reconstruction on either knee
  • Sustained concurrent injury to the contralateral knee
  • Concomitant collateral ligament and/or meniscal repair
  • Presence of symptomatic tibiofemoral osteoarthritis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Virtual reality
Daily 20-minute sessions of virtual reality based rehabilitation for the first 4 weeks post-operatively + standard rehabilitation protocol
Embodiment of a healthy virtual body in virtual reality and action observation/motor imagery of the subject's virtual body performing high-level lower limb exercises.
No Intervention: Standard intervention
Standard rehabilitation protocol only

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The International Knee Documentation Committee (IKDC) Subjective Knee Form
Time Frame: Baseline (day 1 post-surgery)
Patient-completed tool, which contains sections on knee symptoms/pain, function, and sports activities. Scores range from 0 points (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms).
Baseline (day 1 post-surgery)
The International Knee Documentation Committee (IKDC) Subjective Knee Form
Time Frame: 4 weeks
Patient-completed tool, which contains sections on knee symptoms/pain, function, and sports activities. Scores range from 0 points (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms).
4 weeks
The International Knee Documentation Committee (IKDC) Subjective Knee Form
Time Frame: 12 weeks
Patient-completed tool, which contains sections on knee symptoms/pain, function, and sports activities. Scores range from 0 points (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms).
12 weeks
The International Knee Documentation Committee (IKDC) Subjective Knee Form
Time Frame: 9 months
Patient-completed tool, which contains sections on knee symptoms/pain, function, and sports activities. Scores range from 0 points (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms).
9 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Isometric quadriceps strength
Time Frame: Baseline
Measured knee extension strength with a handheld dynamometer, expressed as peak force (Newtons)
Baseline
Isometric quadriceps strength
Time Frame: 4 weeks
Measured knee extension strength with a handheld dynamometer, expressed as peak force (Newtons)
4 weeks
Isometric quadriceps strength
Time Frame: 12 weeks
Measured knee extension strength with a handheld dynamometer, expressed as peak force (Newtons)
12 weeks
Isometric quadriceps strength
Time Frame: 9 months
Measured knee extension strength with a handheld dynamometer, expressed as peak force (Newtons)
9 months
Knee extension active range of motion
Time Frame: Baseline
Measured with a digital goniometer (smartphone app)
Baseline
Knee extension active range of motion
Time Frame: 4 weeks
Measured with a digital goniometer (smartphone app)
4 weeks
Knee extension active range of motion
Time Frame: 12 weeks
Measured with a digital goniometer (smartphone app)
12 weeks
Knee extension active range of motion
Time Frame: 9 months
Measured with a digital goniometer (smartphone app)
9 months
Time taken to return to sporting activity
Time Frame: 9 months
Taken retrospectively at 9 months, number of days from surgery to full return to sport
9 months
Kinesiophobia
Time Frame: Baseline
Fear of movement as measured with the Tampa scale of kinesiophobia
Baseline
Kinesiophobia
Time Frame: 4 weeks
Fear of movement as measured with the Tampa scale of kinesiophobia
4 weeks
Kinesiophobia
Time Frame: 12 weeks
Fear of movement as measured with the Tampa scale of kinesiophobia
12 weeks
Kinesiophobia
Time Frame: 9 months
Fear of movement as measured with the Tampa scale of kinesiophobia
9 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Maria V. Sanchez-Vives, Institut d'Investigacions Biomèdiques August Pi i Sunyer

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2021

Primary Completion (Actual)

November 15, 2023

Study Completion (Actual)

December 15, 2023

Study Registration Dates

First Submitted

September 20, 2021

First Submitted That Met QC Criteria

October 4, 2021

First Posted (Actual)

October 18, 2021

Study Record Updates

Last Update Posted (Actual)

April 18, 2024

Last Update Submitted That Met QC Criteria

April 16, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HCB-2019-0670

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Injuries

Clinical Trials on Virtual reality

3
Subscribe